Skip to main content
Equibles

SEI INVESTMENTS CO

Position in XGN — Exagen Inc.

CIK 350894 OAKS, PA
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$506,873
-$225,847 QoQ
Shares Held
109,005
-55.4% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 57 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,207,468,471 across 33 Diagnostics & Research names. XGN ranks #28 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRL
Charles River Laboratories International, Inc.
 813,530 $184,500,468
2 ICLR
Icon PLC
 902,185 $156,718,555
3 TMO
Thermo Fisher Scientific Inc.
 263,413 $132,064,741
4 DHR
Danaher Corp /De/
 489,535 $93,246,626
5 QGEN
Qiagen N.V.
 2,353,350 $92,015,984
6 LH
Labcorp Holdings Inc.
 264,220 $73,981,600
7 WAT
Waters Corp /De/
 185,985 $69,751,813
8 GH
Guardant Health, Inc.
 346,438 $51,976,092

All Filings in XGN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $506,873 109,005
2026-03-31 $732,720 244,240
2025-12-31 $717,470 118,005